Emenda Therapeutics Ltd
11695185
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
secretary · Since 26/11/2018
director · Since 26/11/2018
PROFESSOR OF SENSORY PHYSIOLOGY
BRITISH · UNITED KINGDOM · Age 59
director · Since 26/11/2018
PROFESSOR IN CHEMISTRY
AUSTRALIAN · AUSTRALIA · Age 57
Persons with Significant Control
Emenda Therapeutics Australia Pty Ltd
16 Nexus Way, Southport, Queensland 4215
Reg: Acn:660040442 · Business Registration Service- Australia · Limited
Notified 01/03/2023
Former PSCs
Professor Lucy Frances Donaldson
Ceased 01/03/2023
Professor Jonathan Morris
Ceased 01/03/2023
Professor David Owen Bates
Ceased 16/07/2021
Professor Steven James Harper
Ceased 01/03/2023
CompanyRankvs 1386+ SIC 72110 peers55
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2024
Net Worth
£3
Balance sheet strength
Cash
£8k
Cash in the bank
Net Current Assets
£26k
Working capital
Current Assets
£27k
Current Liabilities
£934
Debtors
£19k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 28.62 |
| 2022 | 31.87 |
| 2021 | 6.43 |
Derived from filed accounts. Not audited figures.